Paradoxical thrombosis, part 2: anticoagulant and antiplatelet therapy (Q33401497)

26 July 2017

Paradoxical thrombosis, part 2: anticoagulant and antiplatelet therapy (English)

1 reference

26 July 2017

0 references

1 reference

1 reference

2

Emmanuel J Favaloro

1 reference

26 July 2017

1

Giuseppe Lippi

1 reference

26 July 2017

3

Massimo Franchini

1 reference

26 July 2017

1 October 2012

1 reference

Journal of Thrombosis and Thrombolysis

26 July 2017

1 reference

26 July 2017

34

1 reference

26 July 2017

3

1 reference

26 July 2017

367-373

1 reference

https://scigraph.springernature.com/pub.10.1007/s11239-012-0748-0

26 July 2017

0 references

cites work

Arterial thrombus formation in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Relationship between venous and arterial thrombosis: a review of the literature from a causal perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Pathogenesis of venous thromboembolism: when the cup runneth over

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Paradoxical thrombosis part 1: factor replacement therapy, inherited clotting factor deficiencies and prolonged APTT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Unsuspected triggers of venous thromboembolism--trivial or not so trivial?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

The role of ethnicity, age and gender in venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Coagulopathies and thrombosis: usual and unusual causes and associations. Part V.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Preventing postsurgical venous thromboembolism: pharmacological approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Pharmacogenetics of vitamin K antagonists: useful or hype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Warfarin induced skin necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Warfarin-induced skin necrosis associated with acquired protein C deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Laboratory testing of anticoagulants: the present and the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Heparin-induced thrombocytopenia: real-world issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Practical viewpoints on the diagnosis and management of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Evaluating heparin-induced thrombocytopenia: the old and the new.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

A 14-year study of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Current and emerging therapeutics for heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Laboratory assessment and perioperative management of patients on antiplatelet therapy: from the bench to the bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Aspirin therapy: an attempt to explain the events of prothrombotic complications after treatment discontinuation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Paradoxical thrombotic effects of aspirin: experimental study on 1000 animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Thrombocytopenia resulting from sensitivity to GPIIb-IIIa inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Eptifibatide-induced thrombocytopenia and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Drug-induced thrombocytopenia and thrombosis: evidence from patients receiving an oral glycoprotein IIb/IIIa inhibitor in the Orbofiban in Patients with Unstable coronary Syndromes- (OPUS-TIMI 16) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Immune thrombocytopenia caused by glycoprotein IIb/IIIa inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Thrombocytopenia associated with the use of GPIIb/IIIa inhibitors: position paper of the ISTH working group on thrombocytopenia and GPIIb/IIIa inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

High platelet reactivity and antiplatelet therapy resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Thrombotic thrombocytopenic purpura associated with clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Subacute coronary stent thrombosis in a patient developing clopidogrel associated thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Case report: use of thienopyridines in a patient with acquired idiopathic thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0748-0

Recurrent warfarin-induced skin necrosis in kindreds with protein S deficiency

21 January 2018

1 reference

12 December 2020

Thrombotic Thrombocytopenic Purpura associated with Clopidogrel: a case report and review of the literature.

1 reference

12 December 2020

Heparin-induced thrombocytopenia: towards consensus.

1 reference

12 December 2020

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy

1 reference

12 December 2020

Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa.

1 reference

12 December 2020

Warfarin skin necrosis: local and systemic factors

1 reference

12 December 2020

Acquired functional protein S deficiency, cerebral venous thrombosis, and coumarin skin necrosis in association with antiphospholipid syndrome: report of two cases

1 reference

12 December 2020

Warfarin induced skin necrosis associated with activated protein C resistance

1 reference

12 December 2020

Warfarin-induced skin necrosis in HIV-1-infected patients with tuberculosis and venous thrombosis.

1 reference

12 December 2020

A diagnostic test for heparin-induced thrombocytopenia

1 reference

12 December 2020

Clopidogrel-associated thrombotic thrombocytopenic purpura presenting with coronary artery thrombosis

1 reference

12 December 2020

COX-2 inhibition and thrombotic tendency: a need for surveillance

1 reference

12 December 2020

Heparin-induced thrombocytopenia: an update

1 reference

12 December 2020

Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies

1 reference

12 December 2020

New aspects of paradoxical embolism

1 reference

12 December 2020

Coumarin necrosis associated with hereditary protein C deficiency

1 reference

12 December 2020

Warfarin-induced skin necrosis after open heart surgery due to protein S and C deficiency

1 reference

12 December 2020

10.1007/S11239-012-0748-0

Identifiers

DOI

1 reference

release_74ktbbxi7rgdjpc5qundfgg7uy

26 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/74ktbbxi7rgdjpc5qundfgg7uy

24 November 2022

mapped directly with Wikidata item

PubMed ID

22644720

1 reference

PubMed ID

22644720